secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2026-05-26T20:54:31+00:00
Accession:  0001193125-26-239559
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics stockholders elect three Class II directors, ratify KPMG, approve say-on-pay
--------------------------------------------------------------------------------

- Michael M. Morrisey elected with 45.3M For, 13.8M Withheld; Patrick G. Enright with 54.7M For; James R. Meyers with 58.9M For.
- Ratification of KPMG as auditor for FY 2026 approved (61.8M For, 44.7K Against, 87.3K Abstain).
- Advisory vote on executive compensation approved (56.6M For, 2.4M Against, 84.3K Abstain, 2.9M Broker non-votes).
- 71.7M shares outstanding and entitled to vote as of record date March 24, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312526239559/0001193125-26-239559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312526239559/vera-20260521.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-239559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer